Clinical Trials Directory

Trials / Completed

CompletedNCT05280769

Effects of an Oral Nicotine Product in Smokeless Tobacco Users

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to find out how three different nicotine pouches and participant's own brand of smokeless tobacco affect blood nicotine levels and how participants feel.

Conditions

Interventions

TypeNameDescription
OTHERoral nicotine pouch - 2 mg"On" brand oral nicotine pouch with 2 mg of protonated nicotine in "original" flavor
OTHERoral nicotine pouch - 4 mg"On" brand oral nicotine pouch with 4 mg of protonated nicotine in "original" flavor
OTHERoral nicotine pouch - 8 mg"On" brand oral nicotine pouch with 8 mg of protonated nicotine in "original" flavor
OTHERSmokeless tobaccoParticipant's typical brand of smokeless tobacco

Timeline

Start date
2022-08-23
Primary completion
2023-11-28
Completion
2023-11-28
First posted
2022-03-15
Last updated
2024-10-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05280769. Inclusion in this directory is not an endorsement.

Effects of an Oral Nicotine Product in Smokeless Tobacco Users (NCT05280769) · Clinical Trials Directory